These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 19959959)
21. Early piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN study. Rascol O; Dubois B; Caldas AC; Senn S; Del Signore S; Lees A; Mov Disord; 2006 Dec; 21(12):2110-5. PubMed ID: 17013922 [TBL] [Abstract][Full Text] [Related]
22. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. Lim SY; O'Sullivan SS; Kotschet K; Gallagher DA; Lacey C; Lawrence AD; Lees AJ; O'Sullivan DJ; Peppard RF; Rodrigues JP; Schrag A; Silberstein P; Tisch S; Evans AH J Clin Neurosci; 2009 Sep; 16(9):1148-52. PubMed ID: 19553125 [TBL] [Abstract][Full Text] [Related]
23. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A; Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734 [TBL] [Abstract][Full Text] [Related]
24. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Lee JY; Kim JM; Kim JW; Cho J; Lee WY; Kim HJ; Jeon BS Parkinsonism Relat Disord; 2010 Mar; 16(3):202-7. PubMed ID: 20018549 [TBL] [Abstract][Full Text] [Related]
25. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up]. Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540 [TBL] [Abstract][Full Text] [Related]
26. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Tippmann-Peikert M; Park JG; Boeve BF; Shepard JW; Silber MH Neurology; 2007 Jan; 68(4):301-3. PubMed ID: 17242339 [TBL] [Abstract][Full Text] [Related]
27. The relationship between impulsivity and impulse control disorders in Parkinson's disease. Isaias IU; Siri C; Cilia R; De Gaspari D; Pezzoli G; Antonini A Mov Disord; 2008 Feb; 23(3):411-5. PubMed ID: 18067187 [TBL] [Abstract][Full Text] [Related]
28. [Piribedil, dopaminergic agonist. Prolonged clinical and electrophysiological study in 60 parkinsonian patients (author's transl)]. Truelle JL; Chanelet J; Bastard J; Six P; Emile J Nouv Presse Med; 1977 Oct; 6(33):2987-90. PubMed ID: 22844 [TBL] [Abstract][Full Text] [Related]
29. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease. Valença GT; Glass PG; Negreiros NN; Duarte MB; Ventura LM; Mueller M; Oliveira-Filho J Parkinsonism Relat Disord; 2013 Jul; 19(7):698-700. PubMed ID: 23611687 [TBL] [Abstract][Full Text] [Related]
30. Impulse control disorders and pathological gambling in patients with Parkinson disease. Stamey W; Jankovic J Neurologist; 2008 Mar; 14(2):89-99. PubMed ID: 18332838 [TBL] [Abstract][Full Text] [Related]
31. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease. Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P; Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842 [TBL] [Abstract][Full Text] [Related]
32. Pathological gambling caused by drugs used to treat Parkinson disease. Dodd ML; Klos KJ; Bower JH; Geda YE; Josephs KA; Ahlskog JE Arch Neurol; 2005 Sep; 62(9):1377-81. PubMed ID: 16009751 [TBL] [Abstract][Full Text] [Related]
33. Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson's disease. Pontieri FE; Assogna F; Pellicano C; Cacciari C; Pannunzi S; Morrone A; Danese E; Caltagirone C; Spalletta G Eur Neuropsychopharmacol; 2015 Jan; 25(1):69-76. PubMed ID: 25435085 [TBL] [Abstract][Full Text] [Related]
34. Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management. Ceravolo R; Frosini D; Rossi C; Bonuccelli U Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S111-5. PubMed ID: 20123548 [TBL] [Abstract][Full Text] [Related]